Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

NCT00970138 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

141

Enrollment

OTHER

Sponsor class

Conditions

Gastric Carcinoma

Interventions

DRUG: apatinib tablet

Sponsor

Fudan University